Topics

Novo Nordisk A/S: Novo Nordisk files annual report with the SEC

02:41 EST 5 Feb 2019 | FinanzNachrichten

Bagsværd, Denmark, 5 February 2019 - Novo Nordisk A/S has filed its Annual Report 2018 on Form 20-F for the financial year 2018 with the US Securities and Exchange Commission (SEC), incorporating ...

Original Article: Novo Nordisk A/S: Novo Nordisk files annual report with the SEC

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk A/S: Novo Nordisk files annual report with the SEC"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...